Comment on “Calf circumference and risk of cardiovascular disease”
Yung-Wen Cheng
Division of Family Medicine, Department of Family and Community Medicine, Tri-Service General Hospital; and School of Medicine, National Defense Medical Center, Taipei, Taiwan
Search for more papers by this authorChih-Hsuan Hsiang
Division of Geriatric Medicine, Department of Family and Community Medicine, Tri-Service General Hospital; and School of Medicine, National Defense Medical Center, Taipei, Taiwan
Search for more papers by this authorCorresponding Author
Wei-Liang Chen
Division of Family Medicine, Department of Family and Community Medicine, Tri-Service General Hospital; and School of Medicine, National Defense Medical Center, Taipei, Taiwan
Department of Biochemistry, National Defense Medical Center, Taipei, Taiwan
Department of Biochemistry, National Defense Medical Center, Taipei, Taiwan, Republic of China
Search for more papers by this authorYung-Wen Cheng
Division of Family Medicine, Department of Family and Community Medicine, Tri-Service General Hospital; and School of Medicine, National Defense Medical Center, Taipei, Taiwan
Search for more papers by this authorChih-Hsuan Hsiang
Division of Geriatric Medicine, Department of Family and Community Medicine, Tri-Service General Hospital; and School of Medicine, National Defense Medical Center, Taipei, Taiwan
Search for more papers by this authorCorresponding Author
Wei-Liang Chen
Division of Family Medicine, Department of Family and Community Medicine, Tri-Service General Hospital; and School of Medicine, National Defense Medical Center, Taipei, Taiwan
Department of Biochemistry, National Defense Medical Center, Taipei, Taiwan
Department of Biochemistry, National Defense Medical Center, Taipei, Taiwan, Republic of China
Search for more papers by this author
References
- 1Hsiang C-H, Wu C-J, Kao T-W, Chen W-L. Calf circumference and risk of cardiovascular disease. Geriatr Gerontol Int 2020; 20: 1133–1137.
- 2Soysal P. Comment on “calf circumference and risk of cardiovascular disease”. Geriatr Gerontol Int 2021; 21: 117–118.
- 3Roh E, Choi KM. Health consequences of sarcopenic obesity: a narrative review. Front Endocrinol (Lausanne) 2020; 11: 332.
- 4Chen L-K, Woo J, Assantachai P et al. Asian Working Group for Sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment. J Am Med Dir Assoc 2020; 21: 300.e2–307.e2.
- 5Zamboni M, Mazzali G, Fantin F, Rossi A, Di Francesco V. Sarcopenic obesity: a new category of obesity in the elderly. Nutr Metab Cardiovasc Dis 2008; 18: 388–395.
- 6Fakhouri TH, Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of obesity among older adults in the United States, 2007–2010. NCHS Data Brief 2012; 106: 1–8.
- 7Chu NF. Prevalence of obesity in Taiwan. Obes Rev 2005; 6: 271–274.
